- Home
- MGPI vs TNGX Comparison
MGPI vs TNGX Comparison
Compare MGPI & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MGPI | TNGX |
|---|---|---|
| Founded | 1941 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 516.4M | 1.4B |
| IPO Year | 1988 | N/A |
Fundamental Metrics
Financial Performance| Metric | MGPI | TNGX |
|---|---|---|
| Price | $24.21 | $8.63 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $40.00 | $12.50 |
| AVG Volume (30 Days) | 536.3K | ★ 2.3M |
| Earning Date | 10-29-2025 | 11-04-2025 |
| Dividend Yield | ★ 1.98% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $578,855,000.00 | $66,501,000.00 |
| Revenue This Year | N/A | $52.80 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 53.29 |
| 52 Week Low | $21.67 | $1.03 |
| 52 Week High | $40.64 | $11.20 |
Technical Indicators
Market Signals| Indicator | MGPI | TNGX |
|---|---|---|
| Relative Strength Index (RSI) | 47.26 | 44.06 |
| Support Level | $23.46 | $8.30 |
| Resistance Level | $24.32 | $8.82 |
| Average True Range (ATR) | 0.92 | 0.54 |
| MACD | -0.11 | -0.13 |
| Stochastic Oscillator | 24.49 | 17.70 |
Price Performance
Historical ComparisonAbout MGPI MGP Ingredients Inc.
MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives its revenue from the Distillery Solutions segment.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.